IP Library › Granted Patent US 12,329,386
Granted Patent B2
US 12,329,386 · App. 18/507,833 · Granted Jun 17, 2025

Two balloon catheter methods for aspiration and controlled delivery of closure agents

Inventor: Ali Golshan (Santa Monica, CA)
Assignee: Controlled Delivery Systems, Inc.
A61B17/12045A61B17/12031A61B17/12109A61B17/12136A61B17/12186A61B17/320725A61B2017/12127A61B2017/320004A61B2217/005A61M25/007A61M25/1011
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,329,386
App. No.
18/507,833
Granted
Jun 17, 2025
Kind
B2
Abstract

Balloon based therapy devices for treatment of diseased vessels with particular applicability to veins are described. The devices are adapted for active aspiration of a closure zone, in particular aspects to an isolated closure zone, prior to delivery of a closure agent. The devices may be used for treatment of diseased veins in the lower limbs and pelvis. The devices may also include mechanical abrasion elements adapted to engage with a vessel wall, such as along a treatment zone.

Claims (75)

1. A method for closing a portion of an incompetent pelvic vein in a patient, comprising:

accessing the vena cava with a device comprising a distal balloon and a proximal balloon;

navigating the device to the incompetent pelvic vein;

partially inflating the distal balloon to a mechanical treatment volume for engagement with an inner wall of the incompetent pelvic vein, wherein the distal balloon is in a partially inflated state, wherein a volume of the distal balloon in the partially inflated state is less than a volume of the distal balloon in a fully inflated occlusion state;

while maintaining the distal balloon at the mechanical treatment volume, advancing the device along the incompetent pelvic vein to a distal end of a closure zone;

inflating the distal and proximal balloons to the fully inflated occlusion state to occlude the incompetent pelvic vein and form the closure zone between the distal and proximal balloons;

while occluding the incompetent pelvic vein, aspirating a portion of fluid from within the closure zone;

injecting a closure agent into the closure zone; and

maintaining occlusion in the incompetent pelvic vein until a closure agent dwell time has elapsed.

2. The method of claim 1 , further comprising:

deflating the distal and proximal balloons; and withdrawing the device from the patient.

3. The method of claim 1 , further comprising

deflating the distal and proximal balloons;

retracting the device proximally; and

repeating the partially inflating, advancing, inflating, aspirating, injecting, and

maintaining to treat a second closure zone proximal to the closure zone.

4. The method of claim 1 , wherein the incompetent pelvic vein is a gonadal vein, an internal iliac vein, or veins that branch off of the internal iliac or gonadal veins.

5. The method of claim 1 , wherein advancing the device along the incompetent pelvic vein to a distal end of the closure zone comprises injuring the endothelial layer and/or loss of endothelial cells of a diseased vein along the closure zone.

6. The method of claim 5 , wherein after the step of inflating the balloon to a mechanical treatment volume at least one mechanical abrasion element is positioned between a surface of the balloon and a surface of the diseased vein.

7. The method of claim 6 , wherein injuring the endothelial layer is substantially performed by at least one mechanical abrasion element of a mechanical abrasion assembly.

8. The method of claim 1 , wherein the incompetent pelvic vein is a gonadal or internal iliac vein and further comprising aspirating varicosities distal to the distal balloon through a lumen of the device after inflating the distal and proximal balloons to occlude the incompetent pelvic vein and form the closure zone between the distal and proximal balloons.

9. The method of claim 8 , further comprising injecting a closure agent into the varicosities through the lumen.

10. A method for closing a portion of an incompetent pelvic vein in a patient, comprising:

accessing a jugular vein of the patient with a device comprising a distal balloon and a proximal balloon;

navigating the device to the superior vena cava;

navigating the device to the incompetent pelvic vein;

partially inflating the distal balloon to a mechanical treatment volume for engagement with an inner wall of the incompetent pelvic vein, wherein the distal balloon is in a partially inflated state, wherein a volume of the distal balloon in the partially inflated state is less than a volume of the distal balloon in a fully inflated occlusion state;

while maintaining the distal balloon at the mechanical treatment volume, advancing the device along the incompetent pelvic vein to a distal end of a closure zone;

inflating the distal and proximal balloons to the fully inflated occlusion state to occlude the incompetent pelvic vein and form the closure zone between the distal and proximal balloons;

while occluding the incompetent pelvic vein, aspirating a portion of fluid from within the closure zone;

injecting a closure agent into the closure zone; and

maintaining occlusion in the incompetent pelvic vein until a closure agent dwell time has elapsed.

11. The method of claim 10 , wherein the incompetent pelvic vein is an ovarian vein.

12. The method of claim 10 , further comprising deflating the distal and proximal balloons;

retracting the device proximally; and

repeating the partially inflating, advancing, inflating, aspirating, injecting, and

maintaining to treat a second closure zone proximal to the closure zone.

13. The method of claim 12 , wherein the second closure zone is in an incompetent pelvic vein branching off of a gonadal or internal iliac vein and the closure zone is in the gonadal or internal iliac vein.

14. The method of claim 10 , further comprising:

deflating the distal and proximal balloons; and withdrawing the device from the patient.

15. The method of claim 10 , wherein advancing the device along the incompetent pelvic vein to a distal end of the closure zone comprises injuring the endothelial layer and/or loss of endothelial cells of a diseased vein along the closure zone.

16. The method of claim 15 , wherein after the step of inflating the balloon to a mechanical treatment volume at least one mechanical abrasion element is positioned between a surface of the balloon and a surface of the diseased vein.

17. The method of claim 10 , wherein the incompetent pelvic vein is a gonadal or internal iliac vein and further comprising aspirating varicosities distal to the distal balloon through a lumen of the device after inflating the distal and proximal balloons to occlude the incompetent pelvic vein and form the closure zone between the distal and proximal balloons.

18. The method of claim 17 , further comprising injecting a closure agent into the varicosities through the lumen.

19. A method for closing a portion of an incompetent pelvic vein in a patient, comprising:

accessing a femoral vein of the patient with a device comprising a distal balloon and a proximal balloon;

navigating the device to the inferior vena cava;

navigating the device to the incompetent pelvic vein;

partially inflating the distal balloon to a mechanical treatment volume for engagement with an inner wall of the incompetent pelvic vein, wherein the distal balloon is in a partially inflated state, wherein a volume of the distal balloon in the partially inflated state is less than a volume of the distal balloon in a fully inflated occlusion state;

while maintaining the distal balloon at the mechanical treatment volume, advancing the device along the incompetent pelvic vein to a distal end of a closure zone;

inflating the distal and proximal balloons to the fully inflated occlusion state to occlude the incompetent pelvic vein and form the closure zone between the distal and proximal balloons;

while occluding the incompetent pelvic vein, aspirating a portion of fluid from within the closure zone;

injecting a closure agent into the closure zone; and

maintaining occlusion in the incompetent pelvic vein until a closure agent dwell time has elapsed.

20. The method of claim 19 , wherein the incompetent pelvic vein is an ovarian vein.

21. The method of claim 19 , further comprising deflating the distal and proximal balloons;

retracting the device proximally; and repeating the partially inflating, advancing, inflating, aspirating, injecting, and maintaining to treat a second closure zone proximal to the closure zone.

22. The method of claim 21 , wherein the second closure zone is in an incompetent pelvic vein branching off of a gonadal or internal iliac vein and the closure zone is in the gonadal or internal iliac vein.

23. The method of claim 19 , further comprising:

deflating the distal and proximal balloons; and withdrawing the device from the patient.

24. The method of claim 19 , wherein advancing the device along the incompetent pelvic vein to a distal end of the closure zone comprises injuring the endothelial layer and/or loss of endothelial cells of the incompetent pelvic vein along the closure zone using at least one mechanical abrasion element is positioned between a surface of the balloon and a surface of the incompetent pelvic vein.

25. The method of claim 19 , wherein the incompetent pelvic vein is a gonadal or internal iliac vein and further comprising aspirating varicosities distal to the distal balloon through a lumen of the device after inflating the distal and proximal balloons to occlude the incompetent pelvic vein and form the closure zone between the distal and proximal balloons and thereafter injecting a closure agent into the varicosities through a lumen of the device.

26. A method for closing a portion of an incompetent pelvic vein in a patient, comprising:

accessing the vena cava with a device comprising a distal balloon and a proximal balloon;

navigating the device to the incompetent vein over a guidewire positioned in the incompetent pelvic vein;

partially inflating the distal balloon to a mechanical treatment volume for engagement with an inner wall of the incompetent pelvic vein, wherein the distal balloon is in a partially inflated state, wherein a volume of the distal balloon in the partially inflated state is less than a volume of the distal balloon in a fully inflated occlusion state;

while maintaining the distal balloon at the mechanical treatment volume, advancing the device along the incompetent pelvic vein to a distal end of a closure zone;

inflating the distal balloon to the fully inflated occlusion state to occlude the incompetent pelvic vein;

while occluding the incompetent pelvic vein, aspirating a portion of fluid from within the closure zone;

injecting a closure agent into the closure zone; and

maintaining occlusion in the incompetent pelvic vein until a closure agent dwell time has elapsed.

27. The method of claim 26 , wherein the incompetent pelvic vein is a gonadal vein, an internal iliac vein, or veins that branch off of the internal iliac or gonadal veins.

28. The method of claim 26 , wherein advancing the device along the incompetent pelvic vein to a distal end of the closure zone comprises injuring the endothelial layer and/or loss of endothelial cells of a diseased vein along the closure zone using at least one mechanical abrasion element is positioned between a surface of the balloon and a surface of the incompetent pelvic vein.

29. The method of claim 26 , wherein the incompetent pelvic vein is a gonadal or internal iliac vein and further comprising removing the guidewire from a guidewire lumen of the device, aspirating varicosities distal to the distal balloon through the guidewire lumen of the device after inflating the distal balloon to occlude the incompetent pelvic vein and form the closure zone between the distal and proximal balloons and thereafter injecting a closure agent into the varicosities through the guidewire lumen.

30. The method of claim 29 further comprising sequentially performing the steps of aspirating the closure zone and aspirating the varicosities distal to the distal balloon and sequentially performing the steps of injecting a closure agent into the closure zone and injecting a closure agent into the varicosities distal to the distal balloon thereby allowing the closure agent dwell time to be elapsed simultaneously within the closure zone and the varicosities distal to the distal balloon.

Assignments (2)
CHANGE OF NAME Recorded Mar 4, 2025
From: CONTROLLED DELIVERY SYSTEM, INC.
To: SOLVEIN INC.
Reel/Frame 070403/0304 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2023
From: GOLSHAN, ALI
To: CONTROLLED DELIVERY SYSTEMS, INC.
Reel/Frame 065573/0951 →
Continuity (3)
Continuation PCTUS2023078757 · Nov 3, 2023
Provisional Application 63382472 · Nov 4, 2022
Related Publication 20240148387A1 · May 9, 2024
References Cited (225)
US 3625793A · Sheridan et al. · 1971 [cited by applicant]
US 4728319A · Masch · 1988 [cited by applicant]
US 4876109A · Mayer et al. · 1989 [cited by applicant]
US 4895166A · Farr et al. · 1990 [cited by applicant]
US 4983166A · Yamawaki · 1991 [cited by applicant]
US 4990134A · Auth · 1991 [cited by applicant]
US 5011489A · Salem · 1991 [cited by applicant]
US 5022399A · Biegeleisen · 1991 [cited by applicant]
US 5058570A · Idemoto et al. · 1991 [cited by applicant]
US 5074871A · Groshong · 1991 [cited by applicant]
US 5085662A · Willard · 1992 [cited by applicant]
US 5087244A · Wolinsky et al. · 1992 [cited by applicant]
US 5135517A · McCoy · 1992 [cited by applicant]
US 5226909A · Evans et al. · 1993 [cited by applicant]
US 5282484A · Reger · 1994 [cited by applicant]
US 5295959A · Gurbel et al. · 1994 [cited by applicant]
US 5312427A · Shturman · 1994 [cited by applicant]
US 5320604A · Walker et al. · 1994 [cited by applicant]
US 5356418A · Shturman · 1994 [cited by applicant]
US 5361768A · Webler et al. · 1994 [cited by applicant]
US 5370653A · Cragg · 1994 [cited by applicant]
US 5372601A · Lary · 1994 [cited by applicant]
US 5383460A · Jang et al. · 1995 [cited by applicant]
US 5402790A · Jang et al. · 1995 [cited by applicant]
US 5411478A · Stillabower · 1995 [cited by applicant]
US 5415636A · Forman · 1995 [cited by applicant]
US 5540707A · Ressemann et al. · 1996 [cited by applicant]
US 5549601A · McIntyre et al. · 1996 [cited by applicant]
US 5584843A · Wulfman et al. · 1996 [cited by applicant]
US 5628746A · Clayman · 1997 [cited by applicant]
US 5676962A · Cabrera Garrido et al. · 1997 [cited by applicant]
US 5766192A · Zacca · 1998 [cited by applicant]
US 5836905A · Lemelson et al. · 1998 [cited by applicant]
US 5842993A · Eichelberger et al. · 1998 [cited by applicant]
US 5843103A · Wulfman · 1998 [cited by applicant]
US 5851208A · Trott · 1998 [cited by applicant]
US 5882329A · Patterson et al. · 1999 [cited by applicant]
US 5893858A · Spitz · 1999 [cited by applicant]
US 5895400A · Abela · 1999 [cited by applicant]
US 5902266A · Leone et al. · 1999 [cited by applicant]
US 5908395A · Stalker et al. · 1999 [cited by applicant]
US 5919163A · Glickman · 1999 [cited by applicant]
US 5919200A · Stambaugh et al. · 1999 [cited by applicant]
US 5921963A · Erez et al. · 1999 [cited by applicant]
US 5961490A · Adams · 1999 [cited by applicant]
US 6004271A · Moore · 1999 [cited by applicant]
US 6048332A · Duffy et al. · 2000 [cited by applicant]
US RE36764E · Zacca et al. · 2000 [cited by applicant]
US 6090118A · McGuckin · 2000 [cited by applicant]
US 6111614A · Mugura et al. · 2000 [cited by applicant]
US 6159196A · Ruiz · 2000 [cited by applicant]
US 6193735B1 · Stevens · 2001 [cited by applicant]
US 6231518B1 · Grabek et al. · 2001 [cited by applicant]
US 6245040B1 · Inderbitzen et al. · 2001 [cited by applicant]
US 6258087B1 · Edwards et al. · 2001 [cited by applicant]
US 6264633B1 · Knorig · 2001 [cited by applicant]
US 6273882B1 · Whittier et al. · 2001 [cited by applicant]
US 6290675B1 · Vujanic et al. · 2001 [cited by applicant]
US 6306151B1 · Lary · 2001 [cited by applicant]
US 6319227B1 · Mansouri Ruiz · 2001 [cited by applicant]
US 6402745B1 · Wilk · 2002 [cited by applicant]
US 6485482B1 · Belef · 2002 [cited by applicant]
US 6517528B1 · Pantages et al. · 2003 [cited by applicant]
US 6520928B1 · Junior · 2003 [cited by applicant]
US 6602264B1 · McGuckin · 2003 [cited by applicant]
US 6733473B1 · Reifart et al. · 2004 [cited by applicant]
US 6818001B2 · Wulfman et al. · 2004 [cited by applicant]
US 6846412B2 · Hogan et al. · 2005 [cited by applicant]
US 6852118B2 · Shturman et al. · 2005 [cited by applicant]
US 6926725B2 · Cooke et al. · 2005 [cited by applicant]
US 7037316B2 · McGuckin et al. · 2006 [cited by applicant]
US 7077836B2 · Lary et al. · 2006 [cited by applicant]
US 7083643B2 · Whalen et al. · 2006 [cited by applicant]
US 7211073B2 · Fitzgerald et al. · 2007 [cited by applicant]
US 7285126B2 · Sepetka et al. · 2007 [cited by applicant]
US 7402155B2 · Palasis et al. · 2008 [cited by applicant]
US 7419482B2 · Nash et al. · 2008 [cited by applicant]
US 7479147B2 · Honeycutt et al. · 2009 [cited by applicant]
US 7513886B2 · Konstantino · 2009 [cited by applicant]
US 7662143B2 · Carrison et al. · 2010 [cited by applicant]
US 7670328B2 · Miller · 2010 [cited by applicant]
US 7713231B2 · Wulfman et al. · 2010 [cited by applicant]
US 7731986B2 · Wright et al. · 2010 [cited by applicant]
US 7819887B2 · McGuckin et al. · 2010 [cited by applicant]
US 7862575B2 · Tal · 2011 [cited by applicant]
US 7909836B2 · McLean et al. · 2011 [cited by applicant]
US 7967834B2 · Tal et al. · 2011 [cited by applicant]
US 8038664B2 · Miller et al. · 2011 [cited by applicant]
US 8062316B2 · Patel et al. · 2011 [cited by applicant]
US 8122917B2 · Harman et al. · 2012 [cited by applicant]
US 8123770B2 · Olsen et al. · 2012 [cited by applicant]
US 8172783B1 · Ray · 2012 [cited by applicant]
US 8192451B2 · Cambronne et al. · 2012 [cited by applicant]
US 8202244B2 · Cohen et al. · 2012 [cited by applicant]
US 8460214B2 · Kuban et al. · 2013 [cited by applicant]
US 8491539B2 · Fojtik · 2013 [cited by applicant]
US 8632520B2 · Otley · 2014 [cited by applicant]
US 8657821B2 · Palermo · 2014 [cited by applicant]
US 8690833B2 · Belson · 2014 [cited by applicant]
US 8696645B2 · Tal et al. · 2014 [cited by applicant]
US 8764788B2 · Martinez · 2014 [cited by applicant]
US 8992482B2 · Fojtik · 2015 [cited by applicant]
US 8992553B2 · Diamant et al. · 2015 [cited by applicant]
US 9022971B2 · Fojtik · 2015 [cited by applicant]
US 9149612B2 · Chuter · 2015 [cited by applicant]
US 9162037B2 · Belson et al. · 2015 [cited by applicant]
US 9375216B2 · Tal et al. · 2016 [cited by applicant]
US 9440046B2 · Hobbs et al. · 2016 [cited by applicant]
US 9457153B2 · Marano et al. · 2016 [cited by applicant]
US 9463304B2 · Agah et al. · 2016 [cited by applicant]
US 9480467B2 · Marano et al. · 2016 [cited by applicant]
US 9480652B2 · Harman · 2016 [cited by applicant]
US 9585667B2 · Tal et al. · 2017 [cited by applicant]
US 9700347B2 · Shiber · 2017 [cited by applicant]
US 9737329B2 · Shturman · 2017 [cited by applicant]
US RE46581E · Lafontaine et al. · 2017 [cited by applicant]
US 9924957B2 · McGuckin et al. · 2018 [cited by applicant]
US 10207057B2 · Fojtik · 2019 [cited by applicant]
US 10285812B2 · Rowe et al. · 2019 [cited by applicant]
US 10368902B2 · Kessler et al. · 2019 [cited by applicant]
US 10405878B2 · Wasdyke et al. · 2019 [cited by applicant]
US 10555752B2 · Robertson et al. · 2020 [cited by applicant]
US 10561439B2 · Silvestro · 2020 [cited by applicant]
US 10561440B2 · Look et al. · 2020 [cited by applicant]
US 10702300B2 · Higgins et al. · 2020 [cited by applicant]
US 10722694B2 · Konstantino et al. · 2020 [cited by applicant]
US 10786661B2 · Grace · 2020 [cited by applicant]
US 11006935B2 · Brandeis · 2021 [cited by applicant]
US 11065029B2 · McMahon et al. · 2021 [cited by applicant]
US 11420030B2 · Konstantino et al. · 2022 [cited by applicant]
US 11529500B2 · Konstantino et al. · 2022 [cited by applicant]
US 11696793B2 · Anderson et al. · 2023 [cited by applicant]
US 11911581B1 · Golshan · 2024 [cited by examiner]
US 20010041909A1 · Tsugita et al. · 2001 [cited by applicant]
US 20020010487A1 · Evans et al. · 2002 [cited by applicant]
US 20020188276A1 · Evans et al. · 2002 [cited by applicant]
US 20030004568A1 · Ken et al. · 2003 [cited by applicant]
US 20030120256A1 · Lary et al. · 2003 [cited by applicant]
US 20030225435A1 · Huter et al. · 2003 [cited by applicant]
US 20040147934A1 · Kiester · 2004 [cited by applicant]
US 20040219028A1 · Demarais et al. · 2004 [cited by applicant]
US 20040254566A1 · Plicchi et al. · 2004 [cited by applicant]
US 20050033227A1 · Brodersen · 2005 [cited by applicant]
US 20050059931A1 · Garrison et al. · 2005 [cited by applicant]
US 20060149308A1 · Melscheimer · 2006 [cited by applicant]
US 20070016232A1 · St. Martin et al. · 2007 [cited by applicant]
US 20070239140A1 · Chechelski et al. · 2007 [cited by applicant]
US 20080097224A1 · Murphy et al. · 2008 [cited by applicant]
US 20080183129A1 · Silverman et al. · 2008 [cited by applicant]
US 20090105645A1 · Kidd et al. · 2009 [cited by applicant]
US 20090171284A1 · Burke et al. · 2009 [cited by applicant]
US 20100010521A1 · Kurrus · 2010 [cited by applicant]
US 20100217313A1 · Raabe et al. · 2010 [cited by applicant]
US 20100241148A1 · Schon et al. · 2010 [cited by applicant]
US 20100268076A1 · Gat · 2010 [cited by examiner]
US 20110152683A1 · Gerrans et al. · 2011 [cited by applicant]
US 20120059309A1 · di Palma et al. · 2012 [cited by applicant]
US 20120259216A1 · Gerrans et al. · 2012 [cited by applicant]
US 20130018396A1 · Gunderson · 2013 [cited by applicant]
US 20130030410A1 · Drasler · 2013 [cited by examiner]
US 20130294189A1 · Myrick et al. · 2013 [cited by applicant]
US 20150126965A1 · Liungman · 2015 [cited by applicant]
US 20150165169A1 · Mirizzi · 2015 [cited by examiner]
US 20150190127A1 · Madsen et al. · 2015 [cited by applicant]
US 20160242790A1 · Brandeis · 2016 [cited by applicant]
US 20170119428A1 · Boyle et al. · 2017 [cited by applicant]
US 20180056051A1 · Kabra · 2018 [cited by applicant]
US 20180099126A1 · Rousu · 2018 [cited by applicant]
US 20180333563A1 · Agah et al. · 2018 [cited by applicant]
US 20180369539A1 · Rocha-Singh et al. · 2018 [cited by applicant]
US 20190365469A1 · Efremkin · 2019 [cited by applicant]
US 20190374277A1 · Bagwell et al. · 2019 [cited by applicant]
US 20200101269A1 · Hayes et al. · 2020 [cited by applicant]
US 20200113575A1 · Wisnosky et al. · 2020 [cited by applicant]
US 20200113577A1 · Wisnosky et al. · 2020 [cited by applicant]
US 20200121280A1 · Marshall et al. · 2020 [cited by applicant]
US 20200246042A1 · Plowiecki et al. · 2020 [cited by applicant]
US 20200269019A1 · Rollins et al. · 2020 [cited by applicant]
US 20210022816A1 · DeBuys et al. · 2021 [cited by applicant]
US 20210177455A1 · Jamous · 2021 [cited by applicant]
US 20210330370A1 · Macaraeg et al. · 2021 [cited by applicant]
US 20220105108A1 · Seward · 2022 [cited by applicant]
US 20220211983A1 · Giasolli et al. · 2022 [cited by applicant]
US 20220296291A1 · Anderson · 2022 [cited by applicant]
US 20220370715A1 · Vatemacher et al. · 2022 [cited by applicant]
EP 0501081A1 · 1992 [cited by applicant]
EP 0533511A1 · 1993 [cited by applicant]
EP 1267989B1 · 2006 [cited by applicant]
EP 3275498A1 · 2018 [cited by applicant]
JP 2007301392A · 2007 [cited by applicant]
JP 2009254874A · 2009 [cited by applicant]
JP 5622938B2 · 2014 [cited by applicant]
RU 2699009C1 · 2019 [cited by applicant]
RU 196638U1 · 2020 [cited by applicant]
WO WO94021177A1 · 1994 [cited by applicant]
WO WO99004701A1 · 1999 [cited by applicant]
WO WO99047056A1 · 1999 [cited by applicant]
WO WO01008561A1 · 2001 [cited by applicant]
WO WO2014123983A2 · 2014 [cited by applicant]
WO WO2023098708A1 · 2023 [cited by applicant]
WO WO2024045982A1 · 2024 [cited by applicant]
WO WO2024098045A1 · 2024 [cited by applicant]
AETNA_ Pelvic congestion syndrome: treatments; 20 pages; retrived from the internet (https://www.aetna.com/cpb/medical/data/400_499/0441.html) on Jul. 28, 2023. [cited by applicant]
American Medical Association: Code change instructions: 5 pages; retrieved from the internet (https://www.ama-assn.org/print/pdf/node/3146) on Jul. 28, 2023. [cited by applicant]
American Medical Association; CPT code change applications; 5 pages; retrieved from the internet (https://www.ama-assn.org/practice-management/opt/opt-code-change-applications) on Jul. 28, 2023. [cited by applicant]
Centers for Medicare & Medacaid Services; CMS-1751-F; 3 pages; retrieved from the internet (https://www.cms.gov/medicaremedicare-fee-service-paymentphysicianfeeschedpfs-federal-regulation-notices/cms-1751-f) on Jul. 28,… [cited by applicant]
Centers for Medicare & Medicaid Services; Billing and coding: treatment of chronic venous insufficiency of the lower extremities; 10 pages; retrieved from the internet (https://www.cms.gov/medicare-coverage-database/vie… [cited by applicant]
CV Technologies; Flebogrif; 5 pages; retrived from the internet (https://cvtechnologies.in/flebogrif/) on Jul. 28, 2023. [cited by applicant]
Daniels et al.; Effectiveness of embolization or scierotherapy of pelvic veins for reducing chronic pelvic pain; Journal of Vascular and Interventional Radiology: 27(10); pp. 1478-1486;75 pages (Author Manuscript); Oct.… [cited by applicant]
Janatmakan et al.; Effect of local fibrinogen administratiion on postoperative bleeding in open prostatectomy surgery; Anesthesiology and Pain Medicine; 8(3); e73983, 6 pages; Jun. 2018. [cited by applicant]
Marcelin et al.; Diagnosis and management of pelvic venous disorders in females; Diagnostics; 12(10); doi.org/10.3390/diagnostics12102337; 12 pages; Sep. 2022. [cited by applicant]
Phlebolymphology; Treatment options for pelvic congestion syndrome; 11 pages; retrieved from the internet (https://www.phlebolymphology.org/treatment-options-pelvic-congestion-syndrome/) on Jul. 28, 2023. [cited by applicant]
Picel et al.; Endovascular treatment of pelvic congestion syndrome; 5 pages; retrived from the internet (https://assets.bmctoday.net/evtoday/pdfs/et0418_F11_Picel.pdf) on Jul. 28, 2023. [cited by applicant]
Teleflex; Arrrow-trerotola; 12 pages; retrieved from the internet (https://studylib.net/doc/8350860/arrow-trerotola%E2%84%A2-ptd%C2%AE-p) on Jul. 28, 2023. [cited by applicant]
U.S. Food & Drug Administration: Center for Drug Evaluation and research: Varithena / Polidocanol Injectable Foam; 34 pages; retrived from the internet (https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/205098Orig… [cited by applicant]
U.S. Food & Drug Administration; 510(k) Premarket Notification: Clarivein Catheter; 3 pages; retrieved from the internet (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K071468) on Jul. 28, 2023. [cited by applicant]
U.S. Food & Drug; Organge book: approved drug products with therapeutic equivalence evaluations: Polidocanol (Varithena) Solutin 180MG/18ML (10MG/ML); 2 pages; retrieved from the internet (https://www.accessdata.fda.gov… [cited by applicant]
U.S.Food & Drug Administration; Drug approval package:Varithena; 2 pages; retrieved from (https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/205098orig1s000toc.cfm) on Jul. 28, 2023. [cited by applicant]
Varithena; How varithena works; 5 pages; retrieved from the internet (https://www.varithena.com/en-us-hcp/how-it-works.html) on Jul. 23, 2023. [cited by applicant]
Varithena Reimbursement Alert; 3 pages; Available as of Apr. 21, 2022—Wayback Machine Archive; retrived from the internet (https://web.archive.org/web/20220421190800/https://www.varithena.com/content/dam/varithena/hop/4… [cited by applicant]
Golshan; U.S. Appl. No. 18/361,732 entitled “Catheters for the aspiration controlled delivery of closure agents,” filed Jul. 28, 2023. [cited by applicant]
Golshan; U.S. Appl. No. 18/361,757 entitled “Catheters and related methods for the aspiration controlled delivery of closure agents,” filed Jul. 28, 2023. [cited by applicant]
Golshan; U.S. Appl. No. 18/507,948 entitled “Two balloon catheters for aspiration and controlled delivery of closure agents,” filed Nov. 13, 2023. [cited by applicant]
Golshan; U.S. Appl. No. 18/588,474 entitled “Catheters and related methods for the aspiration controlled delivery of closure agents,” filed Feb. 27, 2024. [cited by applicant]
Golshan; U.S. Appl. No. 18/905,106 entitled “Catheters and related methods for the aspiration controlled delivery of closure agents,” filed Oct. 2, 2024. [cited by applicant]